课题基金 / 基金详情

Mechanisms of siRNA mediated broad-spectrum resistance to eukaryotic pathogens

Mechanisms of siRNA mediated broad-spectrum resistance to eukaryotic pathogens
siRNA介导的对真核病原体广谱抗性的机制
批准号:
BB/W00691X/1
负责人:
Wenbo Ma
金额:
$63.37万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Wenbo Ma的其他基金

相似基金

相关文献

中文摘要
翻译
农业的可持续性受到病原体的威胁,病原体对作物产量和食品安全造成重大损害。虽然植物已经进化出无数的免疫机制来保护自己,但成功的病原体可以克服这种监视系统并引起疾病。病原体的毒力因子与宿主的先天免疫之间的动态相互作用决定了疾病是否会发生。为了保护作物免受病原体的侵害,必须识别新的防御机制并了解其功能的分子基础,以设计创新的方法来提高抗病性。最近的研究发现了植物中基于小RNA(sRNA)的防御机制。小RNA是短RNA分子(通常长度为20-24个核苷酸),其基于序列互补性指导靶基因表达的抑制。由sRNA引发的基因沉默或RNA干扰(RNAi)是真核生物中影响广泛生物过程的基本和普遍的调节机制。在宿主-病原体相互作用期间,已经观察到从一种生物体产生的sRNA影响相对生物体中的基因表达。尽管这种“跨物种”RNAi是一个令人兴奋的概念,代表了宿主-病原体军备竞赛的新视角,但仍存在许多挑战。一个根本的挑战是确定植物中哪些sRNA在入侵病原体中执行靶基因沉默。此外,缺乏直接的实验证据证明植物sRNAs在入侵病原体中引导基因沉默。在sRNA可以有效地用于疾病控制之前,需要填补这些主要的知识空白。本研究旨在探讨植物sRNAs在自然感染过程中对病原菌基因沉默的机制。该项目建立在我们最近的发现基础上,这些发现表明植物sRNA的特定家族赋予对丝状真核病原体的抗性。这些sRNA由独特的生物发生途径产生,该途径导致产生多样化的sRNA库,其具有使广泛的真核病原体中的靶基因沉默的潜力。因此,我们确定了一个指定的“抗菌”sRNAs家族,可能赋予广谱resistance.We将使用遗传学,分子生物学,生物化学,合成生物学和植物病理学的方法和模式拟南芥-辣椒疫霉pathosystem研究这个特定的sRNAs家族在植物免疫中的功能。跨物种基因沉默将通过检测蛋白质复合物中的植物sRNA来监测,所述蛋白质复合物指导入侵病原体中的基因沉默。我们将测试的假设,这种新的防御机制赋予广谱抗性,通过检查植物突变体缺陷的sRNA生产的易感性,额外的真核病原体。我们将进一步探索如何编辑sRNA-spawning序列以产生定制的sRNAs,从而增加病原体基因沉默并提高抗性。该项目的成果将为植物免疫的基本原理提供新的见解,并为可持续疾病控制策略的发展提供新的机会,对广泛的病理系统产生深远的影响。
英文摘要
The sustainability of agriculture is threatened by pathogens, which cause substantial damage to crop yield and food safety. Although plants have evolved a myriad of immunity mechanisms to defend themselves, successful pathogens can overcome this surveillance system and cause disease. The dynamic interactions between virulence factors of pathogens and the innate immunity of a host determine whether disease will occur. To protect crops from pathogens, it is essential to identify new defense mechanisms and understand the molecular basis of their functions in order to design innovative approaches to elevate disease resistance.Recent research discovered a small RNA (sRNA)-based defense mechanism in plants. Small RNAs are short RNA molecules (usually 20-24 nucleotide in length) that guide the inhibition of target gene expression based on sequence complementarity. Gene silencing or RNA interference (RNAi) triggered by sRNAs is a fundamental and universal regulatory mechanism in eukaryotes that impacts a wide range of biological processes. During host-pathogen interactions, sRNAs produced from one organism have been observed to affect gene expression in the opposing organism. Although this "trans-species" RNAi is an exciting concept that represents a new perspective in host-pathogen arms race, many challenges remain. A fundamental challenge is to identify which sRNAs in plant execute target genes silencing in invading pathogens. Furthermore, direct experimental evidence demonstrating gene silencing guided by plant sRNAs in invading pathogens is lacking. These major gaps of knowledge need to be filled before sRNAs can be effectively deployed in disease control. In this project, we aim to investigate the mechanism underlying pathogen gene silencing by plant sRNAs during natural infection. This project builds on our recent discoveries suggesting that a specific family of plant sRNAs confer resistance to a filamentous eukaryotic pathogen. These sRNAs are produced from a unique biogenesis pathway that leads to the generation of a diverse sRNA pool, which has the potential to silence target genes in a broad range of eukaryotic pathogens. As such, we identified a designated family of "antimicrobial" sRNAs that may confer broad-spectrum resistance.We will use a combination of genetics, molecular biology, biochemistry, synthetic biology, and plant pathology approaches and the model Arabidopsis thaliana-Phytophthora capsici pathosystem to investigate the function of this specific family of sRNAs in plant immunity. Trans-species gene silencing will be monitored by detection of plant sRNAs in the protein complex that guides gene silencing in the invading pathogen. We will test the hypothesis that this novel defense mechanism confers broad-spectrum resistance by examining plant mutants defective in sRNA production for susceptibility to additional eukaryotic pathogens. We will further explore how sRNA-spawning sequences could be edited to produce bespoke sRNAs that can increase pathogen gene silencing and elevate resistance. The outcome of this project will be to provide novel insight into fundamental principles of plant immunity and offer new opportunities for the development of sustainable disease control strategies with far-reaching implications to a broad range of pathosystems.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
The mechanism of trans-kingdom sRNA trafficking in plant-pathogen interactions
  • 批准号:
    EP/X022846/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $26.0万
  • 财政年份:
    2022
  • 负责人:
    Wenbo Ma
  • 依托单位:
Characterization of a conserved structural and functional module in Phytophthora effectors
  • 批准号:
    BB/W016788/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $61.84万
  • 财政年份:
    2022
  • 负责人:
    Wenbo Ma
  • 依托单位:
Targeting a conserved structural module in Phytophthora effectors for disease resistance
  • 批准号:
    1758889
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $38.16万
  • 财政年份:
    2018
  • 负责人:
    Wenbo Ma
  • 依托单位:
Molecular basis underlying type III effector evolution: discovering the recognition specificity of the diversified HopZ1 alleles in Pseudomonas syringae
  • 批准号:
    0847870
  • 项目类别:
    Standard Grant
  • 资助金额:
    $52.96万
  • 财政年份:
    2009
  • 负责人:
    Wenbo Ma
  • 依托单位:
国内基金
海外基金
基于聚(β-氨基酯)递送Roflumilast/siRNA复合体治疗MASLD相关肝纤维化的作用研究
  • 批准号:
    JCZRQNB202600554
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于多组学联合siRNA-核酸适配体技术的骨髓增生异常综合征靶向治疗研究
  • 批准号:
    2026JJ30092
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张济
  • 依托单位:
功能化破骨前体细胞膜递送双siRNA协同调控骨免疫和骨稳态改善骨质疏松的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    乔方玉
  • 依托单位:
核糖体RNA来源的siRNA通过调控翻译影 响植物干旱响应的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔洁
  • 依托单位: